Since sumoylation of TCF21 could repress the transcriptional activity of ERα, and down-regulate its target genes expression, we speculated that sumoylation of TCF21 may also inhibit the proliferation of ERα-positive breast cancer cells. The gene discussed is TCF21; the disease is breast carcinoma.